Core Scientific, Inc. / Fundamentals
Income statement
- Net revenue
€300.71M - Cost of goods sold
€285.31M - Gross profit
€15.40M - SG&A expenses
€149.42M - R&D expenses
€6.78M - EBITDA
-€624.08M - D&A
€68.46M - EBIT
-€129.35M - Interest expenses
€4.17M - EBT
-€928.66M - Tax expenses
€752.57K - Net income
-€929.41M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.71B - Changes in working capital
-€361.61M - Operating cash flow
€11.15M - Capex
€232.90M - Other investing cash flow
€1.32M - Net investing cash flow
-€235.70M - Total cash dividends paid
€0.00 - Issuance of common stock
-€10.36K - Debt repayment
€1.05B - Other financing cash flow
-€27.97M - Net financing cash flow
€642.47M - Foreign exchange effects
€0.00 - Net change in cash
€417.92M - Cash at end of period
€501.72M - Free cash flow
€244.05M
Balance sheet
- Cash and cash equivalents
€501.72M - Cash and short-term investments
€501.72M - Total receivables
€199.68M - Inventory
€0.00 - Other current assets
€165.74M - Total current assets
€867.14M - Property, plant & equipment
€808.83M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€31.16M - Total non-current assets
€839.99M - Total assets
€1.71B - Accounts payable
€185.60M - Short-term debt
€10.82M - Other current liabilities
€159.67M - Total current liabilities
€485.65M - Long-term debt
€992.43M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.15B - Total non-current liabilities
€2.14B - Total liabilities
€2.63B - Common stock
€2.59K - Retained earnings
-€3.53B - Other equity
€0.00 - Total equity
-€918.85M - Total liabilities and shareholders' equity
€1.71B
Company information
- Market capitalization
€4.23B - Employees
325 - Enterprise Value
€4.14B
Company ratios
- Gross margin
-
5.1% Much worse than peer group: 49.7% - EBITDA margin
-
-207.5% Much worse than peer group: -2.3% - EBIT margin
-
-43.0% Much worse than peer group: -6.2% - EBT margin
-
-308.8% Much worse than peer group: -13.4% - Net margin
-
-309.1% Much worse than peer group: -16.4% - ROE
-
101.1% Much better than peer group: 4.8% - ROA
-
-54.4% Much worse than peer group: 11.6% - Asset turnover
-
17.6% Much worse than peer group: 280.6% - FCF margin
-
-73.7% Much worse than peer group: -4.0% - FCF yield
-5.2% - Efficiency ratio
307.5% - Net sales per employee
-
€925.26K - Net income per employee
-
-€2.86M